MMG, founded in 2019 by Mike Margiotta, is a company strategically positioned to help clinical researchers, pharmaceutical companies, and all those in between. Leveraging decades of executive-level experience, Mike provides consulting services that speed up processes and have been proven to save time and money.
As the original Founder, Chairman & CEO of eHealth Technologies, Michael was able to grow his company from 1 customer & 1 employee to over 250 customers and 120 employees in less than nine years. These customers included 54 of the Top 100 in the country. Michael believes that the key to success is vision, passion and dedication to provide value to his customers. His unwavering dedication to customer service, drove a 97% customer satisfaction and while enjoying a 95% customer retention rate during his leadership.
It is with this same passion that Michael has launched Patient identification Platform™ (Patient i.P.): A technology solution company focused on improving public health and lowering cost by introducing a streamlined process for conducting clinical trials in medicine with greater reliability and patient safety. Patient I.P.™ (Patient identification Platform™) is a first-to-market revolutionary solution, awarded the Microsoft Healthcare Innovation Award in 2016. This award winning software is based on several patent-pending processes, algorithms and displays that comprise our unique visual analytic tools: Patient Matching Index™ (PMI) & Co-Factor Index™ (CFI). The Patient I.P. is an innovative solution focused on automated identification of ideal patients that match the specific requirements for each clinical trial. The platform streamlines the patient matching process, and maximizes the opportunity for a successful trial outcome, while significantly lowering costs.
In Michael’s most recent endeavor, iPatientAxis, a ChartFill company, he launched a first-to-market solution called Predictive Recruitment, which focuses on streamlining patient identification, qualification and enrollment. The Predictive Recruitment solution was readily adopted by the Sponsors, CRO’s and Recruitment companies, but it was the clinical trial sites that really drove demand for this service as it was so positively impactful to their enrollment success. In its first 3 years of business iPatientAxis has successfully supported over 300 studies and 6,000 clinical trial sites. In addition to Predictive Recruitment, iPatientAxis also provides Health Data, Clinical Research, and Transplant Services. Due to demand for global engagement, iPatientAxis expanded its global presence with its first EU office in Dublin, Ireland in August 2019.